Lamba Jasmine, Redfearn Damian P, Michael Kevin A, Simpson Christopher S, Abdollah Hoshiar, Baranchuk Adrian
Department of Medicine, University of Ottawa, Ottawa, Canada.
Pacing Clin Electrophysiol. 2014 Jan;37(1):73-8. doi: 10.1111/pace.12243. Epub 2013 Aug 26.
Frequent idiopathic premature ventricular contractions (PVCs) have been associated with left ventricular cardiomyopathy. Idiopathic PVCs often originate from the right ventricular outflow tract (RVOT), and radiofrequency catheter ablation (RFCA) is being used as a treatment to alleviate symptoms. A meta-analysis was performed to evaluate RFCA for the treatment of frequent idiopathic PVCs on heart function.
A literature search was conducted using Medline and Embase to identify studies evaluating the effects of RFCA as treatment for PVCs originating from the RVOT. Articles were chosen if they reported the effect of RFCA on the quantity of PVCs or ventricular function. Only studies in English were included. Articles were excluded if they did not separate results for PVCs originating from areas other than the RVOT. A total of 450 articles were retrieved from electronic searches, and 14 articles were included in this systematic review. Six of these were meta-analyzed (N = 70) and showed a reduction in the total number of PVCs in 24 hours after RFCA by a mean of -30089.44 confidence interval [CI]: -31658.47, -28520.40, P < 0.00001). Left ventricular ejection fraction (LVEF) was reported in five of the 14 studies, which included 108 patients. RFCA significantly improved LVEF by a mean of 10.36 (CI: 8.75, 11.97, P < 0.00001) in patients with frequent PVCs from the RVOT. The remaining studies reported their results differently and were not included in the meta-analyses but were described separately.
RFCA reduces the number of PVCs and improves the cardiac function in patients with idiopathic frequent PVCs originating from the RVOT.
频发特发性室性早搏(PVC)与左心室心肌病有关。特发性PVC常起源于右心室流出道(RVOT),射频导管消融术(RFCA)正被用作缓解症状的一种治疗方法。进行了一项荟萃分析,以评估RFCA治疗频发特发性PVC对心脏功能的影响。
使用Medline和Embase进行文献检索,以确定评估RFCA治疗起源于RVOT的PVC效果的研究。如果文章报告了RFCA对PVC数量或心室功能的影响,则将其纳入。仅纳入英文研究。如果文章未区分起源于RVOT以外区域的PVC的结果,则将其排除。通过电子检索共检索到450篇文章,本系统评价纳入14篇文章。其中6篇进行了荟萃分析(N = 70),结果显示RFCA术后24小时PVC总数平均减少-30089.44(置信区间[CI]:-31658.47,-28520.40,P < 0.00001)。14项研究中的5项报告了左心室射血分数(LVEF),共纳入108例患者。对于起源于RVOT的频发PVC患者,RFCA使LVEF平均显著提高10.36(CI:8.75,11.97,P < 0.00001)。其余研究报告结果方式不同,未纳入荟萃分析,但单独进行了描述。
RFCA可减少起源于RVOT的特发性频发PVC患者的PVC数量,并改善其心脏功能。